Verastem to Present Long-term Findings on Duvelisib’s Ability to Counter Non-Hodgkin’s Lymphoma
News
Verastem will present long-term findings on duvelisib’s ability to combat non-Hodgkin’s lymphoma at the 14th International Conference on Malignant Lymphoma in Lugano, Switzerland, June 14-17. Forty-six of 129 lymphoma patients in the DYNAMO Phase 2 clinical ... Read more